Literature DB >> 31508270

Immunomodulatory Nanosystems.

Xiangru Feng1,2, Weiguo Xu1, Zhongmin Li1,3, Wantong Song1, Jianxun Ding1, Xuesi Chen1.   

Abstract

Immunotherapy has emerged as an effective strategy for the prevention and treatment of a variety of diseases, including cancer, infectious diseases, inflammatory diseases, and autoimmune diseases. Immunomodulatory nanosystems can readily improve the therapeutic effects and simultaneously overcome many obstacles facing the treatment method, such as inadequate immune stimulation, off-target side effects, and bioactivity loss of immune agents during circulation. In recent years, researchers have continuously developed nanomaterials with new structures, properties, and functions. This Review provides the most recent advances of nanotechnology for immunostimulation and immunosuppression. In cancer immunotherapy, nanosystems play an essential role in immune cell activation and tumor microenvironment modulation, as well as combination with other antitumor approaches. In infectious diseases, many encouraging outcomes from using nanomaterial vaccines against viral and bacterial infections have been reported. In addition, nanoparticles also potentiate the effects of immunosuppressive immune cells for the treatment of inflammatory and autoimmune diseases. Finally, the challenges and prospects of applying nanotechnology to modulate immunotherapy are discussed.

Entities:  

Keywords:  disease treatment; immunostimulation; immunosuppression; immunotherapy; nanotechnology

Year:  2019        PMID: 31508270      PMCID: PMC6724480          DOI: 10.1002/advs.201900101

Source DB:  PubMed          Journal:  Adv Sci (Weinh)        ISSN: 2198-3844            Impact factor:   16.806


  318 in total

1.  Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy.

Authors:  P R Harrigan; M Whaley; J S Montaner
Journal:  AIDS       Date:  1999-05-28       Impact factor: 4.177

2.  Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-06-08       Impact factor: 15.470

3.  Artificial antigen-presenting cells as a tool to exploit the immune 'synapse'.

Authors:  B Prakken; M Wauben; D Genini; R Samodal; J Barnett; A Mendivil; L Leoni; S Albani
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

Review 4.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

5.  Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

Authors:  Marcela V Maus; Anna K Thomas; Debra G B Leonard; David Allman; Kathakali Addya; Katia Schlienger; James L Riley; Carl H June
Journal:  Nat Biotechnol       Date:  2002-02       Impact factor: 54.908

6.  Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages.

Authors:  A Sica; A Saccani; B Bottazzi; N Polentarutti; A Vecchi; J van Damme; A Mantovani
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

7.  Intracellular antibody neutralizes Listeria growth.

Authors:  B T Edelson; E R Unanue
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

8.  Why certain dyes are useful for localizing the sentinel lymph node.

Authors:  Chris Tsopelas; Richard Sutton
Journal:  J Nucl Med       Date:  2002-10       Impact factor: 10.057

9.  Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo.

Authors:  D Hawiger; K Inaba; Y Dorsett; M Guo; K Mahnke; M Rivera; J V Ravetch; R M Steinman; M C Nussenzweig
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

10.  Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.

Authors:  K Nakamura; A Kitani; W Strober
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

View more
  59 in total

1.  Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines.

Authors:  Daniel Shae; Jessalyn J Baljon; Mohamed Wehbe; Plamen P Christov; Kyle W Becker; Amrendra Kumar; Naveenchandra Suryadevara; Carcia S Carson; Christian R Palmer; Frances C Knight; Sebastian Joyce; John T Wilson
Journal:  ACS Nano       Date:  2020-07-31       Impact factor: 15.881

2.  Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot.

Authors:  Zhaoting Li; Lianghan Zhu; Honghao Sun; Yuexin Shen; Dandan Hu; Wenhao Wu; Yixin Wang; Chenggen Qian; Minjie Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-14       Impact factor: 11.205

3.  Dimethylaminomicheliolide Sensitizes Cancer Cells to Radiotherapy for Synergistic Combination with Immune Checkpoint Blockade.

Authors:  Yingying Li; Kaiyuan Ni; Christina Chan; Nining Guo; Taokun Luo; Wenbo Han; August Culbert; Ralph R Weichselbaum; Wenbin Lin
Journal:  Adv Ther (Weinh)       Date:  2021-10-03

4.  Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats.

Authors:  Chunhong Dong; Bao-Zhong Wang
Journal:  Adv Nanobiomed Res       Date:  2021-12-07

Review 5.  Biomedical nanomaterials for immunological applications: ongoing research and clinical trials.

Authors:  Vincent Lenders; Xanthippi Koutsoumpou; Ara Sargsian; Bella B Manshian
Journal:  Nanoscale Adv       Date:  2020-08-24

6.  Rosuvastatin Nanomicelles Target Neuroinflammation and Improve Neurological Deficit in a Mouse Model of Intracerebral Hemorrhage.

Authors:  Liu Zi; Wencheng Zhou; Jiake Xu; Junshu Li; Ning Li; Jianguo Xu; Chao You; Chengwei Wang; Meng Tian
Journal:  Int J Nanomedicine       Date:  2021-04-20

Review 7.  Biocompatibility of nanomaterials and their immunological properties.

Authors:  Themis R Kyriakides; Arindam Raj; Tiffany H Tseng; Hugh Xiao; Ryan Nguyen; Farrah S Mohammed; Saiti Halder; Mengqing Xu; Michelle J Wu; Shuozhen Bao; Wendy C Sheu
Journal:  Biomed Mater       Date:  2021-03-11       Impact factor: 3.715

8.  Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation.

Authors:  Priya Singh; Deepika Singh; Pratikshya Sa; Priyanka Mohapatra; Auromira Khuntia; Sanjeeb K Sahoo
Journal:  Nanomedicine (Lond)       Date:  2021-05-17       Impact factor: 5.307

Review 9.  Prophylactic vaccine delivery systems against epidemic infectious diseases.

Authors:  Chao Pan; Hua Yue; Li Zhu; Guang-Hui Ma; Heng-Liang Wang
Journal:  Adv Drug Deliv Rev       Date:  2021-07-17       Impact factor: 17.873

Review 10.  Drug delivery carriers with therapeutic functions.

Authors:  Shuting S Cai; Tianyu Li; Tolulope Akinade; Yuefei Zhu; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2021-07-21       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.